Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
0.3250
-0.0257 (-7.33%)
At close: Jun 26, 2025, 4:00 PM
0.3412
+0.0162 (4.98%)
Pre-market: Jun 27, 2025, 7:26 AM EDT

Mersana Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
411772805854471,823
Upgrade
Market Cap Growth
-92.11%-36.85%-52.15%30.71%-75.46%564.32%
Upgrade
Enterprise Value
-3753733322761,569
Upgrade
Last Close Price
0.331.432.325.866.2226.61
Upgrade
PS Ratio
1.184.367.5922.0010402.132201.35
Upgrade
PB Ratio
--18.587.586.353.677.99
Upgrade
P/TBV Ratio
--7.586.353.677.99
Upgrade
EV/Sales Ratio
-1.311.9912.486408.321894.81
Upgrade
Debt / Equity Ratio
-0.80-3.010.920.400.320.07
Upgrade
Asset Turnover
0.220.220.130.1000.00
Upgrade
Quick Ratio
1.762.153.293.403.748.50
Upgrade
Current Ratio
1.832.193.363.493.988.62
Upgrade
Return on Equity (ROE)
--505.14%-266.24%-191.03%-97.22%-57.47%
Upgrade
Return on Assets (ROA)
-30.90%-24.73%-38.13%-47.13%-44.02%-28.91%
Upgrade
Return on Capital (ROIC)
-173.22%-101.99%-107.10%-88.01%-52.05%-33.24%
Upgrade
Earnings Yield
-182.71%-39.17%-61.37%-34.93%-38.02%-4.83%
Upgrade
FCF Yield
-195.06%-46.69%-61.14%-8.82%-31.44%-4.12%
Upgrade
Buyback Yield / Dilution
-3.10%-5.54%-23.98%-32.69%-14.79%-41.37%
Upgrade
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q